No Detail Found!

Endocrine Complications in Thalassemic Patients and Its Relation to Genotype

Author(s)
MOHSINA NOOR IBRAHIM Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
SAQIB H ANSARI Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
IBRAHIM SHAKOOR Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
Sajida Erum Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
Misbah Iqbal Hanif Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
Yasir Naqi Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
Jamal Raza Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
Tahir S Shamsi Department of Pediatrics, National Institute of Child Health, Rafiqui Shaheed Road, Karachi, Pakistan
Abstract
Objective: To determine the frequency of endocrine complications in thalassemic patients and their relation with genotype. Study Design: Cross-sectional study. Place and Duration of Study: Division of Endocrinology, Department of Pediatric Hematology, National Institute of Blood Disease & Bone Marrow Transplantation from Jan 2012 to Jan 2015. Methodology: Seventy two diagnosed cases of ß-thalassemia major children on the basis of Hb electrophoresis and DNA amplification by PCR including both male and female of 10-20 years were recruited in the study. Presence of endocrinopathies was evaluated using physical, biochemical and hematological parameters. Results: Short stature and delayed puberty was present in 54(75%) and 51(70.8 %) patients respectively in homozygous and heterozygous ß-thalassemia. Both the complications were most frequently observed in the age group 11-15 yrs. Hypothyroidism, hypoparathyroidism and Insulin Dependent Diabetes Mellitus (IDDM) was present in 10 (13.8%), 2 (2.7%) and 4 (5.6%) patients respectively. All four patients having IDDM belonged to age group 16-20 yrs. Complications were more common in homozygous thalassemics. Conclusion: Prevalence of endocrine complications is high in thalassemic patients of Pakistan. Homozygous thalassemic patients need more strict monitoring for complications and chelation for serum ferritin control.
Publication Details
Page(s) 125-130
DOI DOI not available
Published Journal: Pakistan Paediatric Journal, Volume: 41, Issue: 3, Year: 2017

Request the full text from PASTIC

Keywords
Iron chelation, Pakistan, ß-thalassemia major, Thalassemic complication, Endocrinopathies
0

Citations

0

Downloads

66

Views